Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Correction: quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Dark microglia: A new phenotype predominantly associated with pathological states.
[Optic neuritis: diagnosis, treatment and clinical implications].
Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and upregulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
MRI Mapping of Cerebrovascular Reactivity via Gas Inhalation Challenges.
MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Gammaherpesvirus Infection of Human Neuronal Cells.
Increased B cell and cytotoxic NK cell proportions and increased T cell responsiveness in blood of natalizumab-treated multiple sclerosis patients.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Kinin-mediated inflammation in neurodegenerative disorders.
Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
Simvastatin regulates oligodendroglial process dynamics and survival.
Pages
« first
‹ previous
…
222
223
224
225
226
227
228
229
230
…
next ›
last »